Cystatin C adds prognostic value over conventional predictors of cardiovascular disease outcomes: Results from the long-term intervention with Pravastatin in ischaemic disease (LIPID) trial

  • Malcolm West
  • , David R. Sullivan
  • , Jillian Patterson
  • , Anthony C. Keech
  • , Paul Nestel
  • , Paul P. Glasziou
  • , Adrienne Kirby
  • , Tanja Zeller
  • , David Colquhoun
  • , Stefan Blankenberg
  • , John Simes
  • , Andrew Tonkin
  • , LIPID Study Investigators

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Original languageEnglish
Article number17200
Number of pages2
JournalCirculation
Volume124
Issue numberSuppl 21
Publication statusPublished - 22 Nov 2011
Externally publishedYes
EventScientific Sessions of the American Heart Association/Resuscitation Science Symposium - Orlando, United States
Duration: 12 Nov 201116 Nov 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this